Mosquito control study in Kinshasa
Part of Infections clinical trials.
This trial looks at different ways to control mosquitoes that spread diseases. It will see how well these methods work in households and health facilities in Kinshasa.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be part of a household in one of the 4 selected health areas in Kinshasa.
- You need to be 18 years old or older.
- You must agree to participate and give your consent.
- If you are at a health facility, you must live in the Mont Ngafula 1 health zone.
- You cannot join if you are seriously ill, have clotting disorders, or are pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how to better care for people with fever in the Democratic Republic of the Congo. If you have a fever now or very recently, you may be able to join and help doctors learn more about it.
This study looks for antibiotic-resistant bacteria in the blood of patients with a suspected bloodstream infection. The goal is to understand which antibiotics still work, helping doctors choose the right treatment.
This trial is testing a special device that releases a scent to repel mosquitoes, aiming to reduce malaria in young children in Uganda. If you have a child under 5 and are willing to use the device in your home, this study could help protect your child from malaria.
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
This trial tests a new way to reduce dengue outbreaks by releasing special mosquitoes in public housing areas with active dengue clusters. If your neighborhood has a recent cluster of at least 10 cases, you may be part of the study.
This study looks at whether adding a special device (the Guardian Spatial Emanator) to the AZVINIR II azithromycin program helps prevent malaria. It involves checking households and health centers in high-malaria areas in Africa.
Hear when a new Aedes-borne Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.